Clinical Trial of Cannabis Use Disorder Drug Shows Promise
A first-in-class drug designed to selectively inhibit the cannabinoid receptor signaling pathway shows promise as a safe and effective treatment
Read MoreA first-in-class drug designed to selectively inhibit the cannabinoid receptor signaling pathway shows promise as a safe and effective treatment
Read MoreResearchers from the University of Pennsylvania School of Dental Medicine, the Adams School of Dentistry, and the University of North
Read MoreA global observational study conducted by UCL (University College London) including over 3,200 newborn babies suffering from sepsis in 19
Read MoreEvery year, millions of people in the United States get concussed while participating in sports. Players in sports such as
Read MoreAccording to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and the Broad Institute of
Read MoreA new study published on June 7 by the University of Chicago Education Lab demonstrated that school-based group therapy programs
Read MoreIn an extraordinary example presented by a team at UCL (University College London) and the Royal Free Hospital, three men
Read MoreThe absence of a critical signaling protein in particular immune cells can cause a variety of age-related disorders in young
Read MoreTraditionally, the projected course of a patient’s cancer prognosis has been determined by its kind, stage, and microscopic aggressiveness, although
Read MoreAccording to the US Centers for Disease Control and Prevention, hypertension is a possible death sentence for about half of
Read More